Advancement of GyrB Inhibitors for Treatment of Infections Caused by <i>Mycobacterium tuberculosis</i> and Non-tuberculous Mycobacteria.

Stokes, Suzanne S; Vemula, Rajender; Pucci, Michael J

Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria.

Stokes, Suzanne S; Vemula, Rajender; Pucci, Michael J.

Afiliación

Stokes SS; Spero Therapeutics, 675 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Vemula R; Spero Therapeutics, 675 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Pucci MJ; Spero Therapeutics, 675 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

ACS Infect Dis ; 6(6): 1323-1331, 2020 06 12.

Article en En | MEDLINE | ID: mdl-32183511

Asunto(s)

Mycobacterium tuberculosis; Tuberculosis; Antituberculosos/farmacología; Antituberculosos/uso terapéutico; Humanos; Micobacterias no Tuberculosas; Tuberculosis/tratamiento farmacológico

Palabras clave

ATPase; DNA replication; GyrB; gyrase; non-tuberculous mycobacteria; tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: ACS Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google